معرفی
Mbathio Dieng is a Research Fellow at the University of Sydney's School of Public Health, focusing on health economics, oncology, and patient-centered outcomes. He has advised PhD/Master's students Nazim Bhimani and Jake Williams on projects related to colorectal cancer costs and health technology assessments. His work emphasizes optimizing post-treatment surveillance strategies for melanoma and colorectal cancer patients, including patient-led approaches and integrating environmental impacts into healthcare evaluations.
Dieng collaborates on major trials such as the MEL-SELF (melanoma surveillance), PRIORITY (preoperative cancer rehabilitation), and WashT (neonatal blood transfusion) studies. He has contributed to systematic reviews on healthcare costs, quality of life metrics, and the efficacy of psychoeducational interventions in reducing fear of cancer recurrence. His research also explores cost-effectiveness of imaging modalities like PET/CT for melanoma recurrence detection and the role of electronic patient-reported outcomes in oncology care.
He secured grants including the 2025 PROSPER trial (postoperative pain control), 2018 NHMRC funding for melanoma surveillance studies, and a 2016 Sydney Medical School Kickstart Grant. His interdisciplinary work bridges clinical oncology, public health economics, and patient experience design, addressing both medical and psychosocial aspects of cancer care.